BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 28, 2001
View Archived Issues
Connetics makes changes to focus on dermatology business
Read More
Suppression of cold I/R injury in liver transplantation using p38 MAP kinase inhibitor
Read More
Similar reductions in cytokine production seen in monkeys treated with A-285222 or ciclosporin
Read More
Novel TNF-alpha inhibitor prevents liver failure, promotes liver regeneration following HTx
Read More
Endovasc provides Q1 2001 update
Read More
Small-molecule inhibitor of IKK complex prevents acute cardiac allograft rejection
Read More
Clinical trial demonstrates high response rate to infliximab in psoriasis
Read More
Interneuron reports product update
Read More
ATS 2001: JNK inhibitors as next-generation compounds for asthma
Read More
Xanelim shows promise in treatment of moderate to severe psoriasis
Read More
Efficacy and safety of inhaled insulin maintained over two years in diabetic patients
Read More
Company Profile: EpiGenX
Read More
GlaxoSmithKline's HIV vaccine candidate shows promise in preclinical trials
Read More
Potentially orally active, potent steroidal androgens designed at Organon
Read More
Xyrem provides overall improvement in narcolepsy patients
Read More
Potent, selective, second-generation PDE4 inhibitor with improved safety profile
Read More
Antiischemic agents from SCRAS act on mitochondria
Read More
Investigational anticancer agent phenoxodiol enters first U.S. trial
Read More
Company Profile: CoPharma
Read More
Bisphosphonic acid derivatives and use in treatment, diagnosis of bone diseases
Read More
New osteoclast vacuolar H+-ATPase inhibitors in the AstraZeneca portfolio
Read More
NK-30424 analogues useful as antitumor and antiinflammatory agents
Read More
Squalene synthase inhibitors designed at Eisai inhibit cholesterol biosynthesis
Read More
Novel diazepanes inhibit interaction of LFA-1 with ICAMs
Read More
Cytokine-inhibitory pyrimidines under evaluation at AstraZeneca
Read More